Numinus Wellness Inc reported a big jump in its 1Q 2022 revenue just as Health Canada has expanded its Special Access Program to enable easier access to.
Ended quarter with strong cash position of $53.9 million Revenues grew 245% year-over-year to $0.8 million for the quarter Generated gross profit of $50,965.
Blackhawk s MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder thenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenewswire.com Daily Mail and Mail on Sunday newspapers.